US 10765666
Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering
granted A61KA61K31/437A61P
Quick answer
US patent 10765666 (Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering) held by OVID THERAPEUTICS INC. expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OVID THERAPEUTICS INC.
- Grant date
- Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/437, A61P, A61P25/14